Get the latest Science News and Discoveries

Quarter-million genomes analyzed in NIH project could be ‘hugely important’ for identifying disease risks


None

Get the Android app

Or read this on Science Magazine

Read more on:

Photo of disease risks

disease risks

Photo of NIH

NIH

Photo of Genomes

Genomes

Related news:

News photo

New toolbox allows engineering of genomes without CRISPR

News photo

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

News photo

Omalizumab, a recombinant humanized IgG1 monoclonal antibody, reduces allergic reactions to multiple foods in NIH trial. This could expand the amount of different common foods that children with food allergies can safely consume without eliciting an allergic reaction.